| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |